Download PDF
Horm Metab Res 2013; 45(02): 102-108
DOI: 10.1055/s-0032-1331196
Original Basic
© Georg Thieme Verlag KG Stuttgart · New York

Changes in Differential Gene Expression in Fibroblast Cells from Patients with Triple A Syndrome under Oxidative Stress

K. Koehler   *
1   Division of Endocrinology and Diabetes, Children’s Hospital, Technical University Dresden, Dresden, Germany
,
K. End   *
1   Division of Endocrinology and Diabetes, Children’s Hospital, Technical University Dresden, Dresden, Germany
2   Helios Klinikum Emil von Behring, Children’s Hospital, Berlin, Germany
,
B. Kind
1   Division of Endocrinology and Diabetes, Children’s Hospital, Technical University Dresden, Dresden, Germany
,
D. Landgraf
1   Division of Endocrinology and Diabetes, Children’s Hospital, Technical University Dresden, Dresden, Germany
,
P. Mitzscherling
1   Division of Endocrinology and Diabetes, Children’s Hospital, Technical University Dresden, Dresden, Germany
,
A. Huebner
1   Division of Endocrinology and Diabetes, Children’s Hospital, Technical University Dresden, Dresden, Germany
› Author Affiliations
Further Information

Publication History

received 26 July 2012

accepted 06 November 2012

Publication Date:
11 January 2013 (online)

Also available at
    Permissions and Reprints

Abstract

The triple A syndrome is a rare autosomal recessive disease caused by mutations in the AAAS gene, which encodes the nucleoporin ALADIN. Recently it was shown that ALADIN plays a role in the import of different factors into the nucleus, which prevent the cell from DNA damage and consecutive cell death under oxidative stress. In order to investigate the changes in differential gene expression in ALADIN-deficient or mutated cells under oxidative stress we used fibroblast cell cultures of triple A syndrome patients and compared these to controls. Analysis of 84 genes, which are associated with oxidative stress and antioxidant defense, showed that 7 genes were significantly and differentially regulated, namely BCL2/adenovirus E1B 19kD-interacting protein 3 (BNIP3), 24-dehydrocholesterol reduc­tase (DHCR24), dual specificity phosphatase 1 (DUSP1), forkhead box M1 (FOXM1), nudix-type motif 1 (NUDT1), prostaglandin-endoperoxide synthase 2 (PTGS2), and scavenger receptor class A, member 3 (SCARA3). Whereas in control cells the expression of DHCR24, FOXM1, NUDT1, and SCARA3 was decreased after paraquat treatment, the expression did not change significantly in patient cells. However, the basal expression of SCARA3 and BNIP3 was significantly higher in patient cells than in controls whereas PTGS2 was less expressed. Furthermore, after paraquat treatment the expression of BNIP3, DUSP1, and PTGS2 was significantly increased in control cells while in patient cells the increase of DUSP1 and PTGS2 expression was significantly reduced. With this work we confirm that cells of triple A patients show an altered induction or downregulation of genes associated with oxidative stress and antioxidant defense.

Key words

ALADIN - nucleoporin - oxidative stress - PCR array
*

* K. K. and K. E. contributed equally to this work.


 

  • References

  • 1 Allgrove J, Clayden GS, Grant DB, Macaulay JC. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1978; 1: 1284-1286
    PubMedSearch in Google Scholar
  • 2 Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet 2001; 10: 283-290
    CrossrefPubMedSearch in Google Scholar
  • 3 Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, Bakiri F, Brottier P, Cattolico L, Penet C, Bégeot M, Naville D, Nicolino M, Chaussain JL, Weissenbach J, Munnich A, Lyonnet S. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 2000; 26: 332-335
    CrossrefPubMedSearch in Google Scholar
  • 4 Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002; 158: 915-927
    CrossrefPubMedSearch in Google Scholar
  • 5 Rabut G, Doye V, Ellenberg J. Mapping the dynamic organization of the nuclear pore complex inside single living cells. Nat Cell Biol 2004; 6: 1114-1121
    CrossrefPubMedSearch in Google Scholar
  • 6 Hirano M, Furiya Y, Asai H, Yasui A, Ueno S. ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proc Natl Acad Sci USA 2006; 103: 2298-2303
    CrossrefPubMedSearch in Google Scholar
  • 7 Storr HL, Kind B, Parfitt DA, Chapple JP, Lorenz M, Koehler K, Huebner A, Clark AJ. Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol 2009; 23: 2086-2094
    CrossrefPubMedSearch in Google Scholar
  • 8 Kind B, Koehler K, Krumbholz M, Landgraf D, Huebner A. Intracellular ROS level is increased in fibroblasts of triple A syndrome patients. J Mol Med 2010; 88: 1233-1242
    CrossrefPubMedSearch in Google Scholar
  • 9 Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 4th ed. New York: Oxford University Press; 2007
    Search in Google Scholar
  • 10 Sayre LM, Moreira PI, Smith MA, Perry G. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita 2005; 41: 143-164
    PubMedSearch in Google Scholar
  • 11 Sas K, Robotka H, Toldi J, Vécsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007; 257: 221-239
    CrossrefPubMedSearch in Google Scholar
  • 12 Vallet AE, Verschueren A, Petiot P, Vandenberghe N, Nicolino M, Roman S, Pouget J, Vial C. Neurological features in adult Triple-A (Allgrove) syndrome. J Neurol Sci 2012; 259: 39-46
    CrossrefPubMedSearch in Google Scholar
  • 13 Hoepken HH, Gispert S, Azizov M, Klinkenberg M, Ricciardi F, Kurz A, Morales-Gordo B, Bonin M, Riess O, Gasser T, Kögel D, Steinmetz H, Auburger G. Parkinson patient fibroblasts show increased alpha-synuclein expression. Exp Neurol 2008; 212: 307-313
    CrossrefPubMedSearch in Google Scholar
  • 14 Pedersen CB, Zolkipli Z, Vang S, Palmfeldt J, Kjeldsen M, Stenbroen V, Schmidt SP, Wanders RJ, Ruiter JP, Wibrand F, Tein I, Gregersen N. Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria. J Inherit Metab Dis 2010; 33: 211-222
    PubMedSearch in Google Scholar
  • 15 Campanella A, Privitera D, Guaraldo M, Rovelli E, Barzaghi C, Garavaglia B, Santambrogio P, Cozzi A, Levi S. Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties. Hum Mol Genet 2012; 21: 4049-4059
    CrossrefPubMedSearch in Google Scholar
  • 16 Auburger G, Klinkenberg M, Drost J, Marcus K, Morales-Gordo B, Kunz WS, Brandt U, Broccoli V, Reichmann H, Gispert S, Jendrach M. Primary skin fibroblasts as a model of Parkinson’s disease. Mol Neurobiol 2012; 46: 20-27
    CrossrefPubMedSearch in Google Scholar
  • 17 Peri A, Danza G, Benvenuti S, Luciani P, Deledda C, Rosati F, Cellai I, Serio M. New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm. Front Neuroendocrinol 2009; 30: 119-129
    CrossrefPubMedSearch in Google Scholar
  • 18 Kuehnle K, Crameri A, Kälin RE, Luciani P, Benvenuti S, Peri A, Ratti F, Rodolfo M, Kulic L, Heppner FL, Nitsch RM, Mohajeri MH. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Mol Cell Biol 2008; 28: 539-550
    CrossrefPubMedSearch in Google Scholar
  • 19 Battista MC, Roberge C, Martinez A, Gallo-Payet N. 24-dehydrocholesterol reductase/seladin-1: a key protein differentially involved in adrenocorticotropin effects observed in human and rat adrenal cortex. Endocrinology 2009; 150: 4180-4190
    CrossrefPubMedSearch in Google Scholar
  • 20 Wierstra I, Alves J. FOXM1 a typical proliferation-associated transcription factor. Biol Chem 2007; 388: 1257-1274
    PubMedSearch in Google Scholar
  • 21 Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev 2010; 36: 151-156
    CrossrefPubMedSearch in Google Scholar
  • 22 Park HJ, Carr JR, Wang Z, Nogueira V, Hay N, Tyner AL, Lau LF, Costa RH, Raychaudhuri P. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J 2009; 28: 2908-2918
    CrossrefPubMedSearch in Google Scholar
  • 23 Li SK, Smith DK, Leung WY, Cheung AM, Lam EW, Dimri GP, Yao KM. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J Biol Chem 2008; 283: 16545-16553
    CrossrefPubMedSearch in Google Scholar
  • 24 McLennan AG. The Nudix hydrolase superfamily. Cell Mol Life Sci 2006; 63: 123-143
    CrossrefPubMedSearch in Google Scholar
  • 25 Nakabeppu Y, Kajitani K, Sakamoto K, Yamaguchi H, Tsuchimoto D. MTH1 an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides. DNA Repair 2006; 5: 761-772
    CrossrefPubMedSearch in Google Scholar
  • 26 Greaves DR, Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J Lipid Res 2009; 50: S282-S286
    PubMedSearch in Google Scholar
  • 27 Aguilar-Gaytan R, Mas-Oliva J. Oxidative stress impairs endocytosis of the scavenger receptor class A. Biochem Biophys Res Commun 2003; 305: 510-517
    CrossrefPubMedSearch in Google Scholar
  • 28 Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D’Sa-Eipper C, Chinnadurai G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994; 79: 341-351
    CrossrefPubMedSearch in Google Scholar
  • 29 Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 2009; 16: 939-946
    CrossrefPubMedSearch in Google Scholar
  • 30 Burton TR, Gibson SB. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ 2009; 16: 515-523
    CrossrefPubMedSearch in Google Scholar
  • 31 Rikka S, Quinsay MN, Thomas RL, Kubli DA, Zhang X, Murphy AN, Gustafsson ÅB. Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ 2011; 18: 721-731
    CrossrefPubMedSearch in Google Scholar
  • 32 Bermudez O, Pagès G, Gimond C. The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physiol 2010; 299: C189-C202
    CrossrefPubMedSearch in Google Scholar
  • 33 Wancket LM, Frazier WJ, Liu Y. Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease. Life Sci 2012; 90: 237-248
    CrossrefPubMedSearch in Google Scholar
  • 34 Wu JJ, Bennett AM. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling. J Biol Chem 2005; 280: 16461-16466
    CrossrefPubMedSearch in Google Scholar
  • 35 Zhou JY, Liu Y, Wu GS. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Cancer Res 2006; 66: 4888-4894
    CrossrefPubMedSearch in Google Scholar
  • 36 Musiek ES, Milne GL, McLaughlin B, Morrow JD. Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity. Brain Pathol 2005; 15: 149-158
    PubMedSearch in Google Scholar
  • 37 Choi SH, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 2009; 30: 174-181
    CrossrefPubMedSearch in Google Scholar
  • 38 Ding ZC, Ni FY, Huang ZX. Neuronal growth-inhibitory factor (metal­lothionein-3): structure-function relationships. FEBS J 2010; 277: 2912-2920
    CrossrefPubMedSearch in Google Scholar
  • 39 Howells C, West AK, Chung RS. Neuronal growth-inhibitory factor (metallothionein-3): evaluation of the biological function of growth-inhibitory factor in the injured and neurodegenerative brain. FEBS J 2010; 277: 2931-2939
    CrossrefPubMedSearch in Google Scholar
  • 40 Sogawa CA, Asanuma M, Sogawa N, Miyazaki I, Nakanishi T, Furuta H, Ogawa N. Localization, regulation, and function of metallothionein-III/growth inhibitory factor in the brain. Acta Med Okayama 2001; 55: 1-9
    PubMedSearch in Google Scholar